TargetAlkaline phosphatase, tissue-nonspecific isozyme(Homo sapiens (Human))
Institute for Medical Research
Curated by ChEMBL
Institute for Medical Research
Curated by ChEMBL
Affinity DataKi: 340nMAssay Description:Inhibition of TNAP using CDP-star as substrate by non-competitive Lineweaver-Burk plotMore data for this Ligand-Target Pair
TargetAlkaline phosphatase, tissue-nonspecific isozyme(Homo sapiens (Human))
Institute for Medical Research
Curated by ChEMBL
Institute for Medical Research
Curated by ChEMBL
Affinity DataKi: 590nMAssay Description:Inhibition of TNAP using DEA as substrate by non-competitive Lineweaver-Burk plotMore data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
TargetG-protein coupled receptor 183(Homo sapiens (Human))
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
US Patent
Affinity DataIC50: 5nMAssay Description:The test compounds that demonstrated a corrected % activity of >=50% were defined as inhibitors of the reaction. The experimental values were normali...More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)